Market Currents

• Monday, March 16, 2009

• 09:00 AM Premarket losers: UTHR -10%. ITW -7.8%. SNDK -7%. FLR -5%. MGM -5%. CVTX -5%. Comment!
• 08:50 AM Japan's Astellas Pharma withdraws its $16/share hostile offer for CV Therapeutics (CVTX), saying it can't compete with Gilead Sciences's (GILD) $20/share bid. CVTX -4.8% premarket. GILD +0.7%. Comment!

• Thursday, March 12, 2009

• 09:05 AM Gilead Sciences (GILD) offers to buy CV Therapeutics (CVTX) for $20/share in a deal valued at $1.4B. Gilead expects the purchase to close in Q2 and add to earnings by 2011. Premarket: GILD -3.7%. CVTX +27.5%. Comment!
• 09:01 AM Premarket gainers: CVTX +28%. SIRI +6%. FNM +5%. NOK +4%. PFE +4%. AA +3%. DB +3%. Comment!

• Tuesday, January 27, 2009

• 09:04 AM Japan's Astellas Pharma offers cardio drug developer CV Therapeutics (CVTX) $16/share, a $41 premium. CVTX +48% to $16.77 premarket, signalling belief the offer could be sweetened. Comment!
• 09:00 AM Premarket gainers: CVTX +50%. AIB +21%. RBS +14%. LYG +14%. SLG +10%. NFLX +9%. ENR +9%. X +8%. AFL +7%. BTU +7%. ARMH +6%. FAS +6%. SAY +6%. SI +6%. MT +6%. AXP +6%. AU +5%. BCS +5%. F +5%. NOK +5%. STLD +5%. RTP +5%. BAC +5%. TXN +5%. Comment!

• Thursday, November 6, 2008

• 15:10 PM Notable earnings after Thursday's close: AGO, ALKS, ANH, BBI, BYI, CAR, CBG, CEGE, CVTX, DAR, DIS, FLR, FTI, GNW, HANS, HGSI, IRF, MVSN, NDN, NKTR, NVDA, ONXX, PCLN, PDLI, PSA, PXP, QCOM, SAPE, SD, SWKS, TS, UTSI, VRSN Comment!
• 09:16 AM Premarket gainers: CVI +22%. CVTX +13%. WEN +11%. ATVI +10%. WFMI +9%. YHOO +7%. SLW +6%. RDN +5%. TKC +4%. AUY +4% Comment!
• 00:10 AM Notable earnings after Thursday's close: AGO, ALKS, ANH, BBI, BYI, CAR, CBG, CEGE, CVTX, DAR, DIS, FLR, FTI, GNW, HANS, HGSI, IRF, MVSN, NDN, NKTR, NVDA, ONXX, PCLN, PDLI, PSA, PXP, QCOM, SAPE, SD, SWKS, TS, UTSI, VRSN Comment!